BioStem Technologies, Inc. (BSEM) Misses Q2 EPS by 27c
Tweet
Share
E-mailGet Alerts BSEM Hot Sheet
Join SI Premium – FREE
BioStem Technologies, Inc. (OTC: BSEM) reported Q2 EPS of $0.00, $0.27 worse than the analyst estimate of $0.27. Revenue for the quarter came in at $74.5 million versus the consensus estimate of $44 million.
For earnings history and earnings-related data on BioStem Technologies, Inc. (BSEM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
- HSBC Upgrades Pegatron Corp. (4938:TT) to Hold
- Capstone Energy+, Inc. (CEPL) Reports Q2 Loss of $0.03
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
